Literature review of the efficacy and safety of hyperthermic intraperitoneal perfusion chemotherapy after cytoreductive surgery in the treatment of pseudomyxoma peritonei / 中华胃肠外科杂志
Chinese Journal of Gastrointestinal Surgery
; (12): 132-135, 2011.
Article
в Zh
| WPRIM
| ID: wpr-237155
Ответственная библиотека:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To evaluated the safety and efficacy of hyperthermic intraperitoneal perfusion chemotherapy(HIPC) in the prevention and treatment of pseudomyxoma peritonei (PMP) recurrence after cytoreductive surgery(CRS).</p><p><b>METHODS</b>Studies published in English before 2010 on HIPC after CRS for PMP were searched in PubMed database. Each study was carefully evaluated based on pre-determined criteria. Study results were comprehensively displayed in a form. A descriptive systematic review was performed.</p><p><b>RESULTS</b>A total of 11 studies were included. The median survival time of patients in these studies ranged from 25.6 months to 156 months. The ranges of 1-year, 2-year, 3-year, 5-year, and 10-year survival rates were 72%-100%, 55%-96%, 59%-96%, 52%-96%, and 55%-96%, respectively. The overall complication rate ranged from 2%-15%, and the total perioperative mortality were from 0 to 7%.</p><p><b>CONCLUSION</b>HIPC after CRS is effective and safe for patients with PMP.</p>
Полный текст:
1
База данных:
WPRIM
Основная тема:
Peritoneal Neoplasms
/
Postoperative Care
/
General Surgery
/
Pseudomyxoma Peritonei
/
Chemotherapy, Cancer, Regional Perfusion
/
Treatment Outcome
/
Drug Therapy
/
Methods
Пределы темы:
Humans
Язык:
Zh
Журнал:
Chinese Journal of Gastrointestinal Surgery
Год:
2011
Тип:
Article